# IKZF5

## Overview
IKZF5, also known as Pegasus, is a gene that encodes the IKAROS family zinc finger 5 protein, a member of the Ikaros family of zinc finger transcription factors. This protein plays a pivotal role in the regulation of hematopoiesis and immune system development, primarily through its function as a transcriptional regulator. The IKAROS family zinc finger 5 protein is characterized by its zinc finger domains, which facilitate DNA binding and protein-protein interactions, allowing it to modulate gene expression and chromatin remodeling (Gorzkiewicz2015Functions; John2011The). The gene is expressed across various hematopoietic lineages, with significant implications for megakaryopoiesis, the process of platelet production. Mutations in IKZF5 have been linked to thrombocytopenia, a condition marked by low platelet counts, due to disrupted chromatin binding and impaired platelet formation (Leinoe2020Highly; Lentaigne2019Germline). The protein's unique DNA binding site and its ability to form complexes with other Ikaros family members underscore its critical role in cellular differentiation, proliferation, and survival (Xia2021Ikaros).

## Structure
IKZF5, also known as Pegasus, is a member of the Ikaros family of zinc finger transcription factors. The protein structure of IKZF5 includes three N-terminal zinc fingers responsible for DNA binding, recognizing elements with the core sequence GNNTGTNG (John2011The; Lentaigne2019Germline). These zinc fingers are C2H2-type, which are common in transcription factors and facilitate both DNA binding and protein-protein interactions (Gorzkiewicz2015Functions; John2011The). The C-terminal zinc fingers are involved in dimerization and interaction with other transcriptional regulators, allowing IKZF5 to form stable homo- and heterodimers with other Ikaros family members (Powell2019Ikaros; John2011The).

The primary structure of IKZF5 includes sequences encoding these zinc fingers, and its tertiary structure is stabilized by zinc ion coordination (John2011The). Post-translational modifications, such as phosphorylation, can affect the localization and function of IKZF5 (John2011The). Alternative splicing generates multiple isoforms of IKZF5, which may have differing functional domains (John2011The). These structural features enable IKZF5 to play a crucial role in hematopoiesis and immune regulation.

## Function
IKZF5, also known as Pegasus, is a member of the Ikaros family of zinc finger transcription factors, which are crucial for hematopoiesis and immune system development. In healthy human cells, IKZF5 is involved in the regulation of megakaryopoiesis, the process of platelet production, by influencing the expression of genes essential for platelet formation and function (Lentaigne2019Germline). IKZF5 is expressed across various hematopoietic lineages, but its misregulation specifically affects the megakaryocytic lineage, leading to thrombocytopenia, a condition characterized by low platelet counts (Lentaigne2019Germline).

IKZF5 functions as a transcriptional regulator by binding to DNA through its zinc finger domains, which are crucial for its role in chromatin remodeling and gene expression modulation (John2011The). The protein is active in the nucleus, where it influences cellular processes such as differentiation, proliferation, and survival of hematopoietic cells (Xia2021Ikaros). IKZF5 recognizes an atypical DNA binding site, 'GNNNGNNG', due to its unique N-terminal zinc finger configuration, which distinguishes it from other Ikaros family members (John2011The).

## Clinical Significance
Mutations in the IKZF5 gene are associated with thrombocytopenia, a condition characterized by low platelet counts. Germline mutations in IKZF5 have been identified as a cause of autosomal dominant inherited thrombocytopenia, with affected individuals exhibiting impaired platelet formation and function. These mutations disrupt chromatin binding and reduce proplatelet formation in megakaryocytes, leading to a depletion of alpha granules and altered platelet ultrastructure (Leinoe2020Highly; Lentaigne2019Germline).

Specific IKZF5 variants, such as c.355T>C, p.Ser119Pro and c.48G>C, p.Gln16His, have been linked to thrombocytopenia and bleeding tendencies. These variants are associated with disorganized platelet cytoskeleton proteins and reduced expression of alpha granule proteins, suggesting a pathogenic role in platelet dysfunction (Leinoe2020Highly).

While IKZF5 mutations are primarily linked to thrombocytopenia, there is some evidence suggesting a potential association with immunodeficiency. In one study, a proband with an IKZF5 variant exhibited signs of impaired cellular immunity, although broader immune system issues were not observed in other cases (Leinoe2020Highly; Lentaigne2019Germline).

## Interactions
IKZF5, a member of the Ikaros family of zinc finger proteins, is involved in transcriptional regulation and interacts with other proteins and nucleic acids to modulate gene expression. It can form complexes with other Ikaros family members, which are known to play roles in lymphoid development and immune regulation (Lentaigne2019Germline). IKZF5 mutations have been shown to disrupt DNA binding interactions, as evidenced by structural modeling of specific mutations such as Y89C, C140R, and R96W, which potentially alter the function of IKZF5 by affecting its cellular localization and chromatin binding (Lentaigne2019Germline).

In HEK293 cells, wild-type IKZF5 binds to chromatin in the nucleus, whereas mutant forms exhibit reduced chromatin binding and remain in the cytosol, indicating a disruption in its interaction with chromatin (Lentaigne2019Germline). This impaired chromatin binding is associated with significant changes in the platelet transcriptome, including the downregulation of genes involved in platelet function and hemostasis (Lentaigne2019Germline). These findings suggest that IKZF5's interactions with chromatin and its role in transcriptional regulation are crucial for normal platelet formation and function.


## References


[1. (John2011The) Liza B. John and Alister C. Ward. The ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Molecular Immunology, 48(9–10):1272–1278, May 2011. URL: http://dx.doi.org/10.1016/j.molimm.2011.03.006, doi:10.1016/j.molimm.2011.03.006. This article has 172 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2011.03.006)

[2. (Powell2019Ikaros) Michael D. Powell, Kaitlin A. Read, Bharath K. Sreekumar, and Kenneth J. Oestreich. Ikaros zinc finger transcription factors: regulators of cytokine signaling pathways and cd4+ t helper cell differentiation. Frontiers in Immunology, June 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.01299, doi:10.3389/fimmu.2019.01299. This article has 78 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.01299)

[3. (Leinoe2020Highly) Eva Leinoe, Mimi Kjaersgaard, Eva Zetterberg, Sisse Ostrowski, Andreas Greinacher, and Maria Rossing. Highly impaired platelet ultrastructure in two families with novel ikzf5 variants. Platelets, 32(4):492–497, May 2020. URL: http://dx.doi.org/10.1080/09537104.2020.1764921, doi:10.1080/09537104.2020.1764921. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/09537104.2020.1764921)

[4. (Xia2021Ikaros) Ruolan Xia, Yuan Cheng, Xuejiao Han, Yuquan Wei, and Xiawei Wei. Ikaros proteins in tumor: current perspectives and new developments. Frontiers in Molecular Biosciences, December 2021. URL: http://dx.doi.org/10.3389/fmolb.2021.788440, doi:10.3389/fmolb.2021.788440. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2021.788440)

[5. (Lentaigne2019Germline) Claire Lentaigne, Daniel Greene, Suthesh Sivapalaratnam, Remi Favier, Denis Seyres, Chantal Thys, Luigi Grassi, Sarah Mangles, Keith Sibson, Matthew Stubbs, Frances Burden, Jean-Claude Bordet, Corinne Armari-Alla, Wendy Erber, Samantha Farrow, Nicholas Gleadall, Keith Gomez, Karyn Megy, Sofia Papadia, Christopher J. Penkett, Matthew C. Sims, Luca Stefanucci, Jonathan C. Stephens, Randy J. Read, Kathleen E. Stirrups, Willem H. Ouwehand, Michael A. Laffan, Mattia Frontini, Kathleen Freson, and Ernest Turro. Germline mutations in the transcription factor ikzf5 cause thrombocytopenia. Blood, 134(23):2070–2081, December 2019. URL: http://dx.doi.org/10.1182/blood.2019000782, doi:10.1182/blood.2019000782. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood.2019000782)

[6. (Gorzkiewicz2015Functions) Anna Gorzkiewicz and Anna Walczewska. Functions of the ikaros transcription factor and the role of ikzf1 gene defects in hematological malignancies. Acta Haematologica Polonica, 46(1):10–19, January 2015. URL: http://dx.doi.org/10.1016/j.achaem.2014.10.001, doi:10.1016/j.achaem.2014.10.001. This article has 2 citations.](https://doi.org/10.1016/j.achaem.2014.10.001)